Announcements Trials
Browse Landscape

Phase

Phase 3 12Phase 2 7Phase 1/2 2Phase 1 2Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Positron Emission Tomography Computed Tomography 2fluciclovine F-18 1abemaciclib 1Valproic Acid 1Tetrahydrouridine 1Sirolimus 1Positron-Emission Tomography 1Oncolytic Virotherapy 1Metformin 1Magnetic Resonance Imaging 1Lapatinib 1Ferrosoferric Oxide 1Fatty Acids, Omega-3 1BCG Vaccine 1Aminophylline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Urinary Bladder Neoplasms × BCG Vaccine × Clear all
NCT02326168 2017-01-25

PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed
25 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡